Trials / Unknown
UnknownNCT03268707
Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization
Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization And Quality of Life After Cryoballoon Pulmonary vEin Isolation in Patients With Paroxysmal Atrial Fibrillation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, open, mono-centric pilot study to investigate the influence of an innovative telemetric smartphone application on re-hospitalization and quality of life after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
Detailed description
The telemetric smartphone application includes a digitized medical record, a mobile ECG device and a 24-hour on call service by a cardiologist. The hypothesis is that the use of a telemetric smartphone application can reduce re-hospitalization in patients after cryoballoon pulmonary vein isolation. Secondary endpoints are quality of life measurements, health care cost calculations and recurrences of atrial fibrillation after ablation. All patients will undergo ablation and will be randomized into two groups: 1) conventional follow up with outpatient visits 6 and 12 months after ablation compared to 2) a structured follow up with the smartphone application, a mobile ECG device (patients will be able to send in as many ECGs as wanted), up to three phone calls with a cardiologist (24-hour on call service) as well as outpatient visits 6 and 12 months after cryo-ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Telemetric smartphone application | Structured follow up with a telemetric smartphone application |
| OTHER | Conventional follow up | Conventional follow up at physician practice |
Timeline
- Start date
- 2017-07-15
- Primary completion
- 2020-12-31
- Completion
- 2021-06-30
- First posted
- 2017-08-31
- Last updated
- 2019-06-18
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03268707. Inclusion in this directory is not an endorsement.